Literature DB >> 21525303

Impact of weight on immune cell counts among HIV-infected persons.

Nancy F Crum-Cianflone1, Mollie Roediger, Lynn E Eberly, Anuradha Ganesan, Amy Weintrob, Erica Johnson, Brian K Agan.   

Abstract

Prior studies have shown that weight may impact immune cell counts. However, few data exist about the relationship of weight and immune cell counts among HIV-infected patients. We examined documented HIV seroconverters (mean window, 15.7 months) in a prospective U.S. Military HIV Natural History Study (1 January 1986 to 20 January 2010). We estimated the association of the time-updated body mass index (BMI) category with changes in immune cell counts from HIV diagnosis across time (mean follow-up of 5.1 years) using multiply adjusted longitudinal linear mixed-effects models. Of 1,097 HIV seroconverters, 448 (41%) were overweight and 93 (8%) were obese at HIV diagnosis. Immune cell counts at HIV diagnosis did not significantly differ by BMI category. In the longitudinal models for those diagnosed before the advent of the highly active antiretroviral therapy (HAART) era, mean postdiagnosis decreases in the white cell count, total lymphocyte count, CD4 count, CD4 percentage, and CD4/CD8 ratio were less as the BMI category increased (all with P values of <0.05). Among HIV seroconverters diagnosed in the HAART era, obese compared to normal-weight patients had significantly smaller increases in CD4 counts, CD4 percentages, and the CD4/CD8 ratio (all with P values of <0.05). Similar findings were also noted among underweight versus normal-weight patients. In conclusion, although BMI was not associated with immune cell levels at the time of HIV diagnosis, weight appears to affect immune cells counts over the course of infection. In the HAART era, being either underweight or obese was associated with smaller increases in several important immune cell levels, including the CD4/CD8 ratio.

Entities:  

Mesh:

Year:  2011        PMID: 21525303      PMCID: PMC3122603          DOI: 10.1128/CVI.00020-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  49 in total

1.  Obesity and lymphocyte subsets in virologically suppressed HIV-infected patients.

Authors:  Oluwatoyin M Adeyemi; Sonia Vibhakar; Arthur T Evans
Journal:  Metabolism       Date:  2009-06-18       Impact factor: 8.694

2.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

3.  Reduced tetanus antibody titers in overweight children.

Authors:  Alon Eliakim; Christina Schwindt; Christina Swindt; Frank Zaldivar; Paolo Casali; Dan M Cooper
Journal:  Autoimmunity       Date:  2006-03       Impact factor: 2.815

4.  Are natural killer cells protecting the metabolically healthy obese patient?

Authors:  Lydia A Lynch; Jean M O'Connell; Anna K Kwasnik; Thomas J Cawood; Cliona O'Farrelly; Donal B O'Shea
Journal:  Obesity (Silver Spring)       Date:  2008-12-18       Impact factor: 5.002

5.  Obesity and immune cell counts in women.

Authors:  Julie Womack; Phyllis C Tien; Joseph Feldman; Ja Hyun Shin; Kristopher Fennie; Kathryn Anastos; Mardge H Cohen; Melanie C Bacon; Howard Minkoff
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

6.  Obesity among patients with HIV: the latest epidemic.

Authors:  Nancy Crum-Cianflone; Raechel Tejidor; Sheila Medina; Irma Barahona; Anuradha Ganesan
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

7.  Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.

Authors:  Michael S Boger; Ayumi Shintani; Leigh Anne Redhage; Valerie Mitchell; David W Haas; Jason D Morrow; Todd Hulgan
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

Review 8.  Effect of body mass index on the outcome of infections: a systematic review.

Authors:  M E Falagas; A P Athanasoulia; G Peppas; D E Karageorgopoulos
Journal:  Obes Rev       Date:  2008-02-11       Impact factor: 9.213

9.  The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults?

Authors:  M Bahceci; D Gokalp; S Bahceci; A Tuzcu; S Atmaca; S Arikan
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

10.  Increasing trends in incidence of overweight and obesity over 5 decades.

Authors:  Nisha I Parikh; Michael J Pencina; Thomas J Wang; Katherine J Lanier; Caroline S Fox; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Am J Med       Date:  2007-03       Impact factor: 4.965

View more
  15 in total

1.  High risk of obesity and weight gain for HIV-infected uninsured minorities.

Authors:  Barbara S Taylor; Yuanyuan Liang; L Sergio Garduño; Elizabeth A Walter; Margit B Gerardi; Gregory M Anstead; Delia Bullock; Barbara J Turner
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

2.  Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.

Authors:  Alana T Brennan; Kaitlyn M Berry; Sydney Rosen; Andrew Stokes; Nigel J Crowther; Jaya George; Frederick Raal; Naseem Cassim; Ian Sanne; Lawrence Long; Matthew P Fox
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.177

3.  Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.

Authors:  S S Martinez; A Campa; H Bussmann; S Moyo; J Makhema; F G Huffman; O D Williams; M Essex; R Marlink; M K Baum
Journal:  Br J Nutr       Date:  2016-04-18       Impact factor: 3.718

Review 4.  Metabolic consequences of HIV: pathogenic insights.

Authors:  Amanda L Willig; E Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

5.  Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010.

Authors:  J R Koethe; C A Jenkins; B Lau; B E Shepherd; M J Silverberg; T T Brown; A J Blashill; A Anema; A Willig; S Stinnette; S Napravnik; J Gill; H M Crane; T R Sterling
Journal:  HIV Med       Date:  2015-05-11       Impact factor: 3.180

6.  Body mass index, immune status, and virological control in HIV-infected men who have sex with men.

Authors:  Aaron J Blashill; Kenneth H Mayer; Heidi M Crane; Chris Grasso; Steven A Safren
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-05-29

7.  Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment.

Authors:  John R Koethe; Cathy A Jenkins; Bryan Lau; Bryan E Shepherd; William Wester; Peter F Rebeiro; Michael J Silverberg; Jennifer E Thorne; John Gill; Angel M Mayor; Amanda Willig; Ronald Bosch; Michael A Horberg; Amy C Justice; Timothy R Sterling; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

8.  Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study.

Authors:  F De Salvador-Guillouët; C Sakarovitch; J Durant; K Risso; E Demonchy; P M Roger; E Fontas
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

9.  Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study.

Authors:  Olarinde Jeffrey Ogunmola; Olatunji Yusuf Oladosu; Adeyemi Michael Olamoyegun
Journal:  Vasc Health Risk Manag       Date:  2014-03-18

10.  Leptin at gender-specific concentrations does not affect glucose transport, expression of glucose transporters and leptin receptors in human lymphocytes.

Authors:  Monika Pliszka; Bożenna Oleszczak; Leszek Szablewski
Journal:  Endocrine       Date:  2014-10-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.